Fraunhofer
Also known as: Clinical Airway Research Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany | Fraunhofer Center for Manufacturing Innovation | Fraunhofer, Center for Molecular Biotechnology | Fraunhofer Gesellschaft | Fraunhofer-Gesellschaft | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. | Fraunhofer IME | Fraunhofer institute | Fraunhofer Institute for Molecular Biology and Applied Ecology | Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany | Fraunhofer-Institute of Toxicology and Experimental Medicine | Fraunhofer Institut für Arbeitswirtschaft und Organisation | Fraunhofer ITEM | Fraunhofer ITEM Hannover, Germany | Fraunhofer ITEM in Hannover, Germany | Fraunhofer ITMP | Fraunhofer Portugal AICOS
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2008Last known activity
Jan 31, 2024
Timeline
1940s
- Jun 1, 1949
Fraunhofer— Founded
Drugs by trial phase (34 distinct, 31 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Acne Conglobata
- Anemia
- Anemia, Iron-Deficiency
- Anthrax
- Arthritis
- Arthritis, Psoriatic
- Asthma
- Deficiency Diseases
- Influenza in Birds
- Lung Diseases
- Lung Diseases, Obstructive
- Malaria
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Pulmonary Disease, Chronic Obstructive
- Rheumatic Fever
- Rhinitis
- Rhinitis, Allergic
- Sclerosis
Recent trials (47)
- NCT05727267CollaboratorPhase 1Jan 31, 2024
- NCT05346718Lead sponsorN/ASep 30, 2022
- NCT05346718Reponsible party - principal investigatorN/ASep 30, 2022
- NCT05245175Lead sponsorN/AFeb 22, 2022
- NCT05245175Reponsible party - principal investigatorN/AFeb 22, 2022
- NCT05276375Overall official - principal investigatorPhase 2Jan 14, 2022
- NCT05276375Lead sponsorPhase 2Jan 14, 2022
- NCT05276375Sponsor investigatorPhase 2Jan 14, 2022
- NCT05019209Reponsible party - principal investigatorN/ASep 10, 2021
- NCT05019209Lead sponsorN/ASep 10, 2021
- NCT05144217Study chairPhase 2/Phase 3Jun 23, 2021
- NCT05144217Sponsor investigatorPhase 2/Phase 3Jun 23, 2021
- NCT04914273Lead sponsorN/AJun 14, 2021
- NCT04914273Reponsible party - principal investigatorN/AJun 14, 2021
- NCT05322889Lead sponsorPhase 2Apr 9, 2020
Details
- Founded
- Munich, DE Jun 1, 1949
- Last known activity
- Jan 31, 2024